Monsanto Co. (MON) EVP Steven Mizell Sells 310 Shares of Stock
Monsanto Co. (NYSE:MON) EVP Steven Mizell sold 310 shares of the business’s stock in a transaction on Monday, October 10th. The shares were sold at an average price of $103.09, for a total transaction of $31,957.90. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
Shares of Monsanto Co. (NYSE:MON) opened at 102.32 on Thursday. Monsanto Co. has a 52 week low of $83.73 and a 52 week high of $114.26. The company has a market capitalization of $44.79 billion, a PE ratio of 34.24 and a beta of 1.19. The firm’s 50-day moving average is $104.66 and its 200 day moving average is $101.70.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.09. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The firm had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. During the same period last year, the firm earned ($0.19) EPS. The business’s quarterly revenue was up 8.8% compared to the same quarter last year. On average, analysts anticipate that Monsanto Co. will post $4.89 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be issued a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 2.11%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio is currently 71.05%.
Several research firms have recently commented on MON. Jefferies Group restated a “buy” rating on shares of Monsanto in a report on Tuesday, September 6th. Zacks Investment Research upgraded shares of Monsanto from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 6th. Monness Crespi & Hardt upgraded shares of Monsanto from a “neutral” rating to a “buy” rating and boosted their price target for the company from $106.93 to $130.00 in a report on Monday, August 8th. TheStreet lowered shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, September 12th. Finally, BMO Capital Markets set a $128.00 price objective on shares of Monsanto and gave the company a “buy” rating in a research note on Thursday, September 15th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $114.65.
A number of institutional investors have recently added to or reduced their stakes in MON. Mycio Wealth Partners LLC raised its position in Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares in the last quarter. Moody National Bank Trust Division raised its stake in shares of Monsanto by 0.3% in the second quarter. Moody National Bank Trust Division now owns 4,883 shares of the company’s stock valued at $505,000 after buying an additional 15 shares during the period. Quadrant Capital Group LLC raised its stake in shares of Monsanto by 0.9% in the second quarter. Quadrant Capital Group LLC now owns 1,858 shares of the company’s stock valued at $184,000 after buying an additional 16 shares during the period. Advisor Partners LLC raised its stake in shares of Monsanto by 0.4% in the second quarter. Advisor Partners LLC now owns 6,238 shares of the company’s stock valued at $645,000 after buying an additional 23 shares during the period. Finally, Trust Co. of Vermont raised its stake in shares of Monsanto by 0.6% in the second quarter. Trust Co. of Vermont now owns 4,932 shares of the company’s stock valued at $510,000 after buying an additional 30 shares during the period. 79.02% of the stock is currently owned by hedge funds and other institutional investors.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.